Works by Tsuji, Kunihiko

Results: 102

Impacts of metabolic syndrome diseases on long-term outcomes of chronic hepatitis B patients treated with nucleos(t)ide analogues.

Published in:

Clinical & Molecular Hepatology, 2025, v. 31, n. 3, p. 1003, doi. 10.3350/cmh.2024.1070

By:

Rui Huang;
Dae Won Jun;
Hidenori Toyoda;
Yao-Chun Hsu;
Trinh, Huy;
Akito Nozaki;
Toru Ishikawa;
Tsunamasa Watanabe;
Haruki Uojima;
Huang, Daniel Q.;
Takashi Honda;
Yasuhito Tanaka;
Vutien, Philip;
Marciano, Sebastián;
Hiroshi Abe;
Masaru Enomoto;
Masanori Atsukawa;
Hirokazu Takahashi;
Kunihiko Tsuji;
Koichi Takaguchi

Publication type:

Article

Clinical Impact of Serum CRP Levels on Advanced HCC Treated With Durvalumab and Tremelimumab: A Multicentre Study.

Published in:

Liver International, 2025, v. 45, n. 7, p. 1, doi. 10.1111/liv.70192

By:

Hatanaka, Takeshi;
Yata, Yutaka;
Hiraoka, Atsushi;
Tada, Toshifumi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Kakizaki, Satoru;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Toyoda, Hidenori;
Koshiyama, Yuichi;
Ogawa, Chikara;
Nishikawa, Hiroki;
Nishimura, Takashi

Publication type:

Article

Impact of hepatocellular carcinoma aetiology and liver function on the benefit of surveillance: A novel approach for the adjustment of lead‐time bias.

Published in:

Liver International, 2018, v. 38, n. 12, p. 2260, doi. 10.1111/liv.13927

By:

Toyoda, Hidenori;
Kumada, Takashi;
Tada, Toshifumi;
Mizuno, Kazuyuki;
Hiraoka, Atsushi;
Tsuji, Kunihiko;
Ishikawa, Toru;
Akita, Tomoyuki;
Tanaka, Junko

Publication type:

Article

Lenvatinib as Second-Line Treatment after Atezolizumab plus Bevacizumab for Unresectable Hepatocellular Carcinoma: Clinical Results Show Importance of Hepatic Reserve Function.

Published in:

Oncology, 2023, v. 101, n. 10, p. 624, doi. 10.1159/000531316

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Tada, Toshifumi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Ochi, Hironori;
Yasuda, Satoshi;
Toyoda, Hidenori;
Ogawa, Chikara;
Nishimura, Takashi;
Hatanaka, Takeshi;
Kakizaki, Satoru

Publication type:

Article

Comparison between Atezolizumab Plus Bevacizumab and Lenvatinib for Hepatocellular Carcinoma in Patients with Child-Pugh Class B in Real-World Clinical Settings.

Published in:

Oncology, 2023, v. 101, n. 9, p. 542, doi. 10.1159/000530028

By:

Ohama, Hideko;
Hiraoka, Atsushi;
Tada, Toshifumi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Ochi, Hironori;
Yasuda, Satoshi;
Toyoda, Hidenori;
Ogawa, Chikara;
Nishimura, Takashi;
Hatanaka, Takeshi;
Kakizaki, Satoru

Publication type:

Article

Nutritional Status Is Associated with Prognosis in Patients with Advanced Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab.

Published in:

Oncology, 2023, v. 101, n. 4, p. 270, doi. 10.1159/000527676

By:

Tada, Toshifumi;
Kumada, Takashi;
Hiraoka, Atsushi;
Kariyama, Kazuya;
Tani, Joji;
Hirooka, Masashi;
Takaguchi, Koichi;
Atsukawa, Masanori;
Fukunishi, Shinya;
Itobayashi, Ei;
Tsuji, Kunihiko;
Tajiri, Kazuto;
Ochi, Hironori;
Ishikawa, Toru;
Yasuda, Satoshi;
Ogawa, Chikara;
Toyoda, Hidenori;
Hatanaka, Takeshi;
Nishimura, Takashi;
Kakizaki, Satoru

Publication type:

Article

Clinical Predictor of Urinary Protein as Adverse Event Associated with Atezolizumab plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma.

Published in:

Oncology, 2022, v. 100, n. 12, p. 645, doi. 10.1159/000526521

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Tada, Toshifumi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Ochi, Hironori;
Yasuda, Satoshi;
Toyoda, Hidenori;
Ogawa, Chikara;
Nishimura, Takashi;
Hatanaka, Takeshi;
Kakizaki, Satoru

Publication type:

Article

Simple Scoring System for Predicting TACE Unsuitable among Intermediate-Stage Hepatocellular Carcinoma Patients in the Multiple Systemic Treatment Era.

Published in:

Oncology, 2022, v. 100, n. 2, p. 65, doi. 10.1159/000520292

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Kariyama, Kazuya;
Toyoda, Hidenori;
Yasuda, Satoshi;
Tsuji, Kunihiko;
Hatanaka, Takeshi;
Kakizaki, Satoru;
Naganuma, Atsushi;
Ishikawa, Toru;
Tada, Toshifumi;
Takaguchi, Koichi;
Itobayashi, Ei;
Shimada, Noritomo;
Shibata, Hiroshi;
Tanaka, Takaaki;
Tsutsui, Akemi;
Nagano, Takuya;
Imai, Michitaka;
Nakamura, Shinichiro

Publication type:

Article

Impact of Early Lenvatinib Administration on Survival in Patients with Intermediate-Stage Hepatocellular Carcinoma: A Multicenter, Inverse Probability Weighting Analysis.

Published in:

Oncology, 2021, v. 99, n. 8, p. 518, doi. 10.1159/000515896

By:

Tada, Toshifumi;
Kumada, Takashi;
Hiraoka, Atsushi;
Michitaka, Kojiro;
Atsukawa, Masanori;
Hirooka, Masashi;
Tsuji, Kunihiko;
Ishikawa, Toru;
Takaguchi, Koichi;
Kariyama, Kazuya;
Itobayashi, Ei;
Tajiri, Kazuto;
Shimada, Noritomo;
Shibata, Hiroshi;
Ochi, Hironori;
Yasuda, Satoshi;
Toyoda, Hidenori;
Fukunishi, Shinya;
Ohama, Hideko;
Kawata, Kazuhito

Publication type:

Article

Nutritional Index as Prognostic Indicator in Patients Receiving Lenvatinib Treatment for Unresectable Hepatocellular Carcinoma.

Published in:

Oncology, 2020, v. 98, n. 5, p. 295, doi. 10.1159/000506293

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Tada, Toshifumi;
Fukunishi, Shinya;
Atsukawa, Masanori;
Hirooka, Masashi;
Tsuji, Kunihiko;
Ishikawa, Toru;
Takaguchi, Koichi;
Kariyama, Kazuya;
Itobayashi, Ei;
Tajiri, Kazuto;
Shimada, Noritomo;
Shibata, Hiroshi;
Ochi, Hironori;
Kawata, Kazuhito;
Toyoda, Hidenori;
Ohama, Hideko;
Tsutsui, Akemi;
Itokawa, Norio

Publication type:

Article

Early Relative Change in Hepatic Function with Lenvatinib for Unresectable Hepatocellular Carcinoma.

Published in:

Oncology, 2019, v. 97, n. 6, p. 334, doi. 10.1159/000502095

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Atsukawa, Masanori;
Hirooka, Masashi;
Tsuji, Kunihiko;
Ishikawa, Toru;
Takaguchi, Koichi;
Kariyama, Kazuya;
Itobayashi, Ei;
Tajiri, Kazuto;
Shimada, Noritomo;
Shibata, Hiroshi;
Ochi, Hironori;
Tada, Toshifumi;
Toyoda, Hidenori;
Nouso, Kazuhiro;
Tsutsui, Akemi;
Nagano, Takuya;
Itokawa, Norio;
Hayama, Korenobu

Publication type:

Article

Important Clinical Factors in Sequential Therapy Including Lenvatinib against Unresectable Hepatocellular Carcinoma.

Published in:

Oncology, 2019, v. 97, n. 5, p. 277, doi. 10.1159/000501281

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Atsukawa, Masanori;
Hirooka, Masashi;
Tsuji, Kunihiko;
Ishikawa, Toru;
Takaguchi, Koichi;
Kariyama, Kazuya;
Itobayashi, Ei;
Tajiri, Kazuto;
Shimada, Noritomo;
Shibata, Hiroshi;
Ochi, Hironori;
Tada, Toshifumi;
Toyoda, Hidenori;
Nouso, Kazuhiro;
Tsutsui, Akemi;
Nagano, Takuya;
Itokawa, Norio;
Hayama, Korenobu

Publication type:

Article

Proposed New Sub-Grouping for Intermediate-Stage Hepatocellular Carcinoma Using Albumin-Bilirubin Grade.

Published in:

Oncology, 2016, v. 91, n. 3, p. 153, doi. 10.1159/000447061

By:

Hiraoka, atsushi;
Kumada, Takashi;
Nouso, Kazuhiro;
Tsuji, Kunihiko;
Itobayashi, Ei;
Hirooka, Masashi;
Kariyama, Kazuya;
Ishikawa, Toru;
Tada, Toshifumi;
Toyoda, Hidenori;
Kawasaki, Hideki;
Hiasa, Yoichi;
Michitaka, Kojiro

Publication type:

Article

Attempt to Establish Prognostic Predictive System for Hepatocellular Carcinoma Using Artificial Intelligence for Assistance with Selection of Treatment Modality.

Published in:

Liver Cancer (2235-1795), 2023, v. 12, n. 6, p. 565, doi. 10.1159/000530078

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Tada, Toshifumi;
Toyoda, Hidenori;
Kariyama, Kazuya;
Hatanaka, Takeshi;
Kakizaki, Satoru;
Naganuma, Atsushi;
Itobayashi, Ei;
Tsuji, Kunihiko;
Ishikawa, Toru;
Ohama, Hideko;
Tada, Fujimasa;
Nouso, Kazuhiro

Publication type:

Article

Relationship of Atezolizumab plus Bevacizumab Treatment with Muscle Volume Loss in Unresectable Hepatocellular Carcinoma Patients: Multicenter Analysis.

Published in:

Liver Cancer (2235-1795), 2023, v. 12, n. 3, p. 209, doi. 10.1159/000527402

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Tada, Toshifumi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Ochi, Hironori;
Yasuda, Satoshi;
Toyoda, Hidenori;
Ogawa, Chikara;
Nishimura, Takashi;
Hatanaka, Takeshi;
Kakizaki, Satoru

Publication type:

Article

What Can Be Done to Solve the Unmet Clinical Need of Hepatocellular Carcinoma Patients following Lenvatinib Failure?

Published in:

Liver Cancer (2235-1795), 2021, v. 10, n. 2, p. 115, doi. 10.1159/000513355

By:

Atsushi Hiraoka;
Takashi Kumada;
Toshifumi Tada;
Kazuya Kariyama;
Joji Tani;
Shinya Fukunishi;
Masanori Atsukawa;
Masashi Hirooka;
Kunihiko Tsuji;
Toru Ishikawa;
Koichi Takaguchi;
Ei Itobayashi;
Kazuto Tajiri;
Noritomo Shimada;
Hiroshi Shibata;
Hironori Ochi;
Kazuhito Kawata;
Satoshi Yasuda;
Hidenori Toyoda;
Hideko Ohama

Publication type:

Article

EZ-ALBI Score for Predicting Hepatocellular Carcinoma Prognosis.

Published in:

Liver Cancer (2235-1795), 2020, v. 9, n. 6, p. 734, doi. 10.1159/000508971

By:

Kariyama, Kazuya;
Nouso, Kazuhiro;
Hiraoka, Atsushi;
Wakuta, Akiko;
Oonishi, Ayano;
Kuzuya, Teiji;
Toyoda, Hidenori;
Tada, Toshifumi;
Tsuji, Kunihiko;
Itobayashi, Ei;
Ishikawa, Toru;
Takaguchi, Koichi;
Tsutsui, Akemi;
Shimada, Noritomo;
Kudo, Masatoshi;
Kumada, Takashi

Publication type:

Article

Post-Progression Treatment Eligibility of Unresectable Hepatocellular Carcinoma Patients Treated with Lenvatinib.

Published in:

Liver Cancer (2235-1795), 2020, v. 9, n. 1, p. 73, doi. 10.1159/000503031

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Fukunishi, Shinya;
Atsukawa, Masanori;
Hirooka, Masashi;
Tsuji, Kunihiko;
Ishikawa, Toru;
Takaguchi, Koichi;
Kariyama, Kazuya;
Itobayashi, Ei;
Tajiri, Kazuto;
Shimada, Noritomo;
Shibata, Hiroshi;
Ochi, Hironori;
Tada, Toshifumi;
Toyoda, Hidenori;
Yokohama, Keisuke;
Nouso, Kazuhiro;
Tsutsui, Akemi;
Nagano, Takuya

Publication type:

Article

Treatment of Intermediate-Stage Hepatocellular Carcinoma in Japan: Position of Curative Therapies.

Published in:

Liver Cancer (2235-1795), 2020, v. 9, n. 1, p. 41, doi. 10.1159/000502479

By:

Kariyama, Kazuya;
Nouso, Kazuhiro;
Wakuta, Akiko;
Oonishi, Ayano;
Toyoda, Hidenori;
Tada, Toshifumi;
Hiraoka, Atsushi;
Tsuji, Kunihiko;
Itobayashi, Ei;
Ishikawa, Toru;
Takaguchi, Koichi;
Tsutsui, Akemi;
Shimada, Noritomo;
Kumada, Takashi

Publication type:

Article

Predictive factors and survival outcome of conversion therapy for unresectable hepatocellular carcinoma patients receiving atezolizumab and bevacizumab: Comparative analysis of conversion, partial response and complete response patients.

Published in:

Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 10, p. 1361, doi. 10.1111/apt.18237

By:

Hatanaka, Takeshi;
Kakizaki, Satoru;
Hiraoka, Atsushi;
Tada, Toshifumi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Toyoda, Hidenori;
Ogawa, Chikara;
Nishikawa, Hiroki;
Nishimura, Takashi;
Kawata, Kazuhito;
Kosaka, Hisashi

Publication type:

Article

Outcomes of patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab in real‐world clinical practice who met or did not meet the inclusion criteria for the phase 3 IMbrave150 trial.

Published in:

Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 2, p. 233, doi. 10.1111/apt.18037

By:

Tada, Toshifumi;
Kumada, Takashi;
Hiraoka, Atsushi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Nishikawa, Hiroki;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Koshiyama, Yuichi;
Toyoda, Hidenori;
Ogawa, Chikara;
Hatanaka, Takeshi;
Kakizaki, Satoru;
Kawata, Kazuhito

Publication type:

Article

Role of hepatic resection in patients with intermediate-stage hepatocellular carcinoma: A multicenter study from Japan.

Published in:

Cancer Science, 2017, v. 108, n. 7, p. 1414, doi. 10.1111/cas.13257

By:

Tada, Toshifumi;
Kumada, Takashi;
Toyoda, Hidenori;
Tsuji, Kunihiko;
Hiraoka, Atsushi;
Itobayashi, Ei;
Nouso, Kazuhiro;
Kariyama, Kazuya;
Ishikawa, Toru;
Hirooka, Masashi;
Hiasa, Yoichi

Publication type:

Article

Utility of serological tumor biomarkers for surveillance of hepatocellular carcinoma in patients undergoing dialysis.

Published in:

Nephrology Dialysis Transplantation, 2021, v. 36, n. 6, p. 1097, doi. 10.1093/ndt/gfaa165

By:

Toyoda, Hidenori;
Kikuchi, Kan;
Tsuruta, Yuki;
Hiraoka, Atsushi;
Tsuji, Kunihiko;
Tanaka, Junko

Publication type:

Article

Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions—Multicenter analysis.

Published in:

Cancer Medicine, 2019, v. 8, n. 8, p. 3719, doi. 10.1002/cam4.2241

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Atsukawa, Masanori;
Hirooka, Masashi;
Tsuji, Kunihiko;
Ishikawa, Toru;
Takaguchi, Koichi;
Kariyama, Kazuya;
Itobayashi, Ei;
Tajiri, Kazuto;
Shimada, Noritomo;
Shibata, Hiroshi;
Ochi, Hironori;
Tada, Toshifumi;
Toyoda, Hidenori;
Nouso, Kazuhiro;
Tsutsui, Akemi;
Nagano, Takuya;
Itokawa, Norio;
Hayama, Korenobu

Publication type:

Article

Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions: Multicenter analysis.

Published in:

Cancer Medicine, 2019, v. 8, n. 1, p. 137, doi. 10.1002/cam4.1909

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Kariyama, Kazuya;
Takaguchi, Koichi;
Atsukawa, Masanori;
Itobayashi, Ei;
Tsuji, Kunihiko;
Tajiri, Kazuto;
Hirooka, Masashi;
Shimada, Noritomo;
Shibata, Hiroshi;
Ishikawa, Toru;
Ochi, Hironori;
Tada, Toshifumi;
Toyoda, Hidenori;
Nouso, Kazuhiro;
Tsutsui, Akemi;
Itokawa, Norio;
Imai, Michitaka;
Joko, Kouji

Publication type:

Article

Geriatric nutritional risk index and newly developed scoring system as prognosis prediction for unresectable hepatocellular carcinoma patients treated with lenvatinib.

Published in:

Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-024-78539-4

By:

Ohama, Hideko;
Hiraoka, Atsushi;
Tada, Toshifumi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Ochi, Hironori;
Yasuda, Satoshi;
Toyoda, Hidenori;
Ogawa, Chikara;
Nishimura, Takashi;
Hatanaka, Takeshi;
Kakizaki, Satoru

Publication type:

Article

Improved survival of viral hepatocellular carcinoma but not non‐viral hepatocellular carcinoma from 2000 to 2020: A multi‐centre cohort study of 6007 patients from high‐volume academic centres in Japan.

Published in:

Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 4, p. 694, doi. 10.1111/apt.17088

By:

Toyoda, Hidenori;
Kariyama, Kazuya;
Hiraoka, Atsushi;
Tsuji, Kunihiko;
Ishikawa, Toru;
Hatanaka, Takeshi;
Naganuma, Atsushi;
Yasuda, Satoshi;
Nouso, Kazuhiro;
Kakizaki, Satoru;
Kumada, Takashi;
Innes, Hamish;
Johnson, Philip J.

Publication type:

Article

The efficacy and safety of glecaprevir plus pibrentasvir in 141 patients with severe renal impairment: a prospective, multicenter study.

Published in:

Alimentary Pharmacology & Therapeutics, 2019, v. 49, n. 9, p. 1230, doi. 10.1111/apt.15218

By:

Atsukawa, Masanori;
Tsubota, Akihito;
Toyoda, Hidenori;
Takaguchi, Koichi;
Nakamuta, Makoto;
Watanabe, Tsunamasa;
Michitaka, Kojiro;
Ikegami, Tadashi;
Nozaki, Akito;
Uojima, Haruki;
Fukunishi, Shinya;
Genda, Takuya;
Abe, Hiroshi;
Hotta, Naoki;
Tsuji, Kunihiko;
Ogawa, Chikara;
Tachi, Yoshihiko;
Shima, Toshihide;
Shimada, Noritomo;
Kondo, Chisa

Publication type:

Article

Identification of CT Values That Could Be Predictive of Necrosis (N-CTav) in Hepatocellular Carcinoma after Lenvatinib Treatment.

Published in:

Current Oncology, 2022, v. 29, n. 5, p. 3259, doi. 10.3390/curroncol29050266

By:

Chuma, Makoto;
Yokoo, Hideki;
Hiraoka, Atsushi;
Ueda, Kazuhiko;
Yokoyama, Takahiro;
Tsuji, Kunihiko;
Shimada, Noritomo;
Uojima, Haruki;
Kobayashi, Satoshi;
Hattori, Nobuhiro;
Okubo, Tomomi;
Atsukawa, Masanori;
Ishikawa, Toru;
Takaguchi, Koichi;
Tsutsui, Akemi;
Toyoda, Hidenori;
Tada, Toshifumi;
Saito, Yoshinori;
Hirose, Shunji;
Tanaka, Takaaki

Publication type:

Article

Independent Association Between Improvement of Nonalcoholic Fatty Liver Disease and Reduced Incidence of Type 2 Diabetes.

Published in:

Diabetes Care, 2015, v. 38, n. 9, p. 1673, doi. 10.2337/dc15-0140

By:

Hajime Yamazaki;
Toru Tsuboya;
Kunihiko Tsuji;
Mitsuru Dohke;
Hiroyuki Maguchi

Publication type:

Article

Characteristics and Prognosis of Hepatocellular Carcinoma in Japanese Patients Undergoing Dialysis.

Published in:

Therapeutic Apheresis & Dialysis, 2017, v. 21, n. 5, p. 465, doi. 10.1111/1744-9987.12563

By:

Toyoda, Hidenori;
Hiraoka, Atsushi;
Tada, Toshifumi;
Michitaka, Kojiro;
Takaguchi, Koichi;
Tsuji, Kunihiko;
Itobayashi, Ei;
Takizawa, Daichi;
Hirooka, Masashi;
Koizumi, Yohei;
Ochi, Hironori;
Joko, Koji;
Kisaka, Yoshiyasu;
Shimizu, Yuko;
Tajiri, Kazuto;
Tani, Joji;
Taniguchi, Tatsuya;
Toshimori, Akiko;
Fujioka, Shinichi;
Kumada, Takashi

Publication type:

Article

Potential of PALBI‐T score as a prognostic model for hepatocellular carcinoma in alcoholic liver disease.

Published in:

JGH Open, 2022, v. 6, n. 1, p. 36, doi. 10.1002/jgh3.12705

By:

Tanaka, Kazunari;
Tsuji, Kunihiko;
Matsui, Takeshi;
Kang, Jong‐Hon;
Sakurai, Yasuo;
Kodama, Yoshihisa;
Minami, Ryosuke;
Watanabe, Kiichi;
Katanuma, Akio

Publication type:

Article

Integrated Predictors by Propensity Scoring With Tumor Markers and Plasma Levels of microRNA-21-5p, IL-17, and IL-10 Complement Early Detection of Hepatocellular Carcinoma in Patients With Liver Cirrhosis.

Published in:

Technology in Cancer Research & Treatment, 2023, p. 1, doi. 10.1177/15330338231212084

By:

Machida, Maiko;
Ambo, Mayuko;
Mishina, Runa;
Hada, Nanaka;
Tachibana, Fuhito;
Yamashita, Miki;
Konda, Ainari;
Tsuji, Kunihiko

Publication type:

Article

Therapeutic efficacy of ramucirumab after lenvatinib for post-progression treatment of unresectable hepatocellular carcinoma.

Published in:

Gastroenterology Report, 2021, v. 9, n. 2, p. 133, doi. 10.1093/gastro/goaa042

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Tada, Toshifumi;
Ogawa, Chikara;
Tani, Joji;
Fukunishi, Shinya;
Atsukawa, Masanori;
Hirooka, Masashi;
Tsuji, Kunihiko;
Ishikawa, Toru;
Takaguchi, Koichi;
Kariyama, Kazuya;
Itobayashi, Ei;
Tajiri, Kazuto;
Shimada, Noritomo;
Shibata, Hiroshi;
Ochi, Hironori;
Kawata, Kazuhito;
Toyoda, Hidenori;
Ohama, Hideko

Publication type:

Article

Survival Outcomes Associated With Radiological Progressive Disease Subtypes in Patients With Atezolizumab and Bevacizumab–Treated HCC.

Published in:

Journal of Gastroenterology & Hepatology, 2025, v. 40, n. 4, p. 949, doi. 10.1111/jgh.16884

By:

Matono, Tomomitsu;
Tada, Toshifumi;
Kumada, Takashi;
Hiraoka, Atsushi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Nishikawa, Hiroki;
Tanaka, Kazunari;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Koshiyama, Yuichi;
Toyoda, Hidenori;
Ogawa, Chikara;
Hatanaka, Takeshi

Publication type:

Article

Reliable Performance of mALBI Grade‐Based Risk Models for Predicting the Prognosis of Patients With Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab as First‐Line Treatment: Comparative Analysis of 13 Risk Models.

Published in:

Journal of Gastroenterology & Hepatology, 2025, v. 40, n. 4, p. 930, doi. 10.1111/jgh.16871

By:

Hatanaka, Takeshi;
Kakizaki, Satoru;
Hiraoka, Atsushi;
Tada, Toshifumi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Toyoda, Hidenori;
Ogawa, Chikara;
Nishikawa, Hiroki;
Nishimura, Takashi;
Kawata, Kazuhito;
Kosaka, Hisashi

Publication type:

Article

Changes in clinical outcomes in Japanese patients with hepatocellular carcinoma due to hepatitis C virus following the development of direct‐acting antiviral agents.

Published in:

Journal of Gastroenterology & Hepatology, 2024, v. 39, n. 7, p. 1394, doi. 10.1111/jgh.16553

By:

Ohama, Hideko;
Hiraoka, Atsushi;
Tada, Toshifumi;
Kariyama, Kazuya;
Itobayashi, Ei;
Tsuji, Kunihiko;
Ishikawa, Toru;
Toyoda, Hidenori;
Hatanaka, Takeshi;
Kakizaki, Satoru;
Naganuma, Atsushi;
Tada, Fujimasa;
Tanaka, Hironori;
Nakamura, Shinichiro;
Nouso, Kazuhiro;
Tanaka, Kazunari;
Kumada, Takashi

Publication type:

Article

Comparison of six hepatocellular carcinoma prediction models in Japanese patients after sustained virologic response undergoing rigorous surveillance for hepatocellular carcinoma.

Published in:

Journal of Gastroenterology & Hepatology, 2024, v. 39, n. 5, p. 949, doi. 10.1111/jgh.16494

By:

Toyoda, Hidenori;
Tada, Toshifumi;
Uojima, Haruki;
Nozaki, Akito;
Chuma, Makoto;
Takaguchi, Koichi;
Hiraoka, Atsushi;
Abe, Hiroshi;
Itobayashi, Ei;
Matsuura, Kentaro;
Atsukawa, Masanori;
Watanabe, Tsunamasa;
Shimada, Noritomo;
Nakamuta, Makoto;
Kojima, Motoyuki;
Tsuji, Kunihiko;
Mikami, Shigeru;
Ishikawa, Toru;
Yasuda, Satoshi;
Tsutsui, Akemi

Publication type:

Article

Impact of first‐line systemic therapy with atezolizumab plus bevacizumab in patients with hepatocellular carcinoma.

Published in:

Journal of Gastroenterology & Hepatology, 2023, v. 38, n. 8, p. 1389, doi. 10.1111/jgh.16225

By:

Tada, Toshifumi;
Kumada, Takashi;
Hiraoka, Atsushi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Ochi, Hironori;
Yasuda, Satoshi;
Toyoda, Hidenori;
Ogawa, Chikara;
Nishimura, Takashi;
Hatanaka, Takeshi;
Kakizaki, Satoru

Publication type:

Article

Clinical importance of muscle volume in lenvatinib treatment for hepatocellular carcinoma: Analysis adjusted with inverse probability weighting.

Published in:

Journal of Gastroenterology & Hepatology, 2021, v. 36, n. 7, p. 1812, doi. 10.1111/jgh.15336

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Kariyama, Kazuya;
Tada, Toshifumi;
Tani, Joji;
Fukunishi, Shinya;
Atsukawa, Masanori;
Hirooka, Masashi;
Tsuji, Kunihiko;
Ishikawa, Toru;
Takaguchi, Koichi;
Itobayashi, Ei;
Tajiri, Kazuto;
Shimada, Noritomo;
Shibata, Hiroshi;
Ochi, Hironori;
Kawata, Kazuhito;
Yasuda, Satoshi;
Toyoda, Hidenori;
Ohama, Hideko

Publication type:

Article

Marked heterogeneity in the diagnosis of compensated cirrhosis of patients with chronic hepatitis C virus infection in a real‐world setting: A large, multicenter study from Japan.

Published in:

Journal of Gastroenterology & Hepatology, 2020, v. 35, n. 8, p. 1420, doi. 10.1111/jgh.14982

By:

Toyoda, Hidenori;
Atsukawa, Masanori;
Watanabe, Tsunamasa;
Nakamuta, Makoto;
Uojima, Haruki;
Nozaki, Akito;
Takaguchi, Koichi;
Fujioka, Shinichi;
Iio, Etsuko;
Shima, Toshihide;
Akahane, Takehiro;
Fukunishi, Shinya;
Asano, Toru;
Michitaka, Kojiro;
Tsuji, Kunihiko;
Abe, Hiroshi;
Mikami, Shigeru;
Okubo, Hironao;
Okubo, Tomomi;
Shimada, Noritomo

Publication type:

Article

Real‐world experience of 12‐week direct‐acting antiviral regimen of glecaprevir and pibrentasvir in patients with chronic hepatitis C virus infection.

Published in:

Journal of Gastroenterology & Hepatology, 2020, v. 35, n. 5, p. 855, doi. 10.1111/jgh.14874

By:

Toyoda, Hidenori;
Atsukawa, Masanori;
Watanabe, Tsunamasa;
Nakamuta, Makoto;
Uojima, Haruki;
Nozaki, Akito;
Takaguchi, Koichi;
Fujioka, Shinichi;
Iio, Etsuko;
Shima, Toshihide;
Akahane, Takehiro;
Fukunishi, Shinya;
Asano, Toru;
Michitaka, Kojiro;
Tsuji, Kunihiko;
Abe, Hiroshi;
Mikami, Shigeru;
Okubo, Hironao;
Okubo, Tomomi;
Shimada, Noritomo

Publication type:

Article

Impact of albumin–bilirubin grade on survival in patients with hepatocellular carcinoma who received sorafenib: An analysis using time‐dependent receiver operating characteristic.

Published in:

Journal of Gastroenterology & Hepatology, 2019, v. 34, n. 6, p. 1066, doi. 10.1111/jgh.14564

By:

Tada, Toshifumi;
Kumada, Takashi;
Toyoda, Hidenori;
Tsuji, Kunihiko;
Hiraoka, Atsushi;
Michitaka, Kojiro;
Deguchi, Akihiro;
Ishikawa, Toru;
Imai, Michitaka;
Ochi, Hironori;
Joko, Koji;
Shimada, Noritomo;
Tajiri, Kazuto;
Hirooka, Masashi;
Koizumi, Yohei;
Hiasa, Yoichi;
Tanaka, Junko

Publication type:

Article

Efficacy and safety of elbasvir/grazoprevir for Japanese patients with genotype 1b chronic hepatitis C complicated by chronic kidney disease, including those undergoing hemodialysis: A post hoc analysis of a multicenter study.

Published in:

Journal of Gastroenterology & Hepatology, 2019, v. 34, n. 2, p. 364, doi. 10.1111/jgh.14447

By:

Atsukawa, Masanori;
Kondo, Chisa;
Iwakiri, Katsuhiko;
Asano, Toru;
Ishikawa, Toru;
Abe, Hiroshi;
Kato, Keizo;
Tsuji, Kunihiko;
Ogawa, Chikara;
Shimada, Noritomo;
Iio, Etsuko;
Tanaka, Yasuhito;
Mikami, Shigeru;
Tsubota, Akihito;
Matsumoto, Yoshihiro;
Toyoda, Hidenori;
Kumada, Takashi;
Takaguchi, Koichi;
Okubo, Tomomi;
Hiraoka, Atsushi

Publication type:

Article

Impact of FIB-4 index on hepatocellular carcinoma incidence during nucleos(t)ide analogue therapy in patients with chronic hepatitis B: An analysis using time-dependent receiver operating characteristic.

Published in:

Journal of Gastroenterology & Hepatology, 2017, v. 32, n. 2, p. 451, doi. 10.1111/jgh.13473

By:

Tada, Toshifumi;
Kumada, Takashi;
Toyoda, Hidenori;
Tsuji, Kunihiko;
Hiraoka, Atsushi;
Tanaka, Junko

Publication type:

Article

Hepatic Function during Repeated TACE Procedures and Prognosis after Introducing Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: Multicenter Analysis.

Published in:

Digestive Diseases, 2017, v. 35, n. 6, p. 602, doi. 10.1159/000480256

By:

Atsushi Hiraoka;
Takashi Kumada;
Masatoshi Kudo;
Masashi Hirooka;
Yohei Koizumi;
Yoichi Hiasa;
Kazuto Tajiri;
Hidenori Toyoda;
Toshifumi Tada;
Hironori Ochi;
Koji Joko;
Noritomo Shimada;
Akihiro Deguchi;
Toru Ishikawa;
Michitaka Imai;
Kunihiko Tsuji;
Kojiro Michitaka

Publication type:

Article

ORIGINAL ARTICLE Efficacy and long-term outcome of laparoscopic microwave coagulation or radiofrequency ablation therapy for surface-type hepatocellular carcinoma.

Published in:

Digestive Endoscopy, 2004, v. 16, n. 2, p. 117, doi. 10.1111/j.1443-1661.2003.00323.x

By:

Tsuji, Kunihiko;
Nishimori, Hiroyuki;
Sakurai, Yasuo;
Mitsui, Shinya;
Miyamoto, Noriyuki;
Matsunaga, Takahiro;
Kang, Jong-Hon;
Maguchi, Hiroyuki;
Maekubo, Hiroshi

Publication type:

Article

International multicenter validation of GES score for HCC risk stratification in chronic hepatitis C patients.

Published in:

Journal of Viral Hepatitis, 2022, v. 29, n. 9, p. 807, doi. 10.1111/jvh.13717

By:

Shiha, Gamal;
Soliman, Reham;
Mikhail, Nabiel N. H.;
Carrat, Fabrice;
Azzi, Jessica;
Nathalie, Ganne‐Carrié;
Toyoda, Hidenori;
Uojima, Haruki;
Nozaki, Akito;
Takaguchi, Koichi;
Hiraoka, Atsushi;
Atsukawa, Masanori;
Abe, Hiroshi;
Matsuura, Kentaro;
Mikami, Shigeru;
Watanabe, Tsunamasa;
Tsuji, Kunihiko;
Ishikawa, Toru;
Suri, Vithika;
Osinusi, Anu

Publication type:

Article

Factors linked to hepatocellular carcinoma development beyond 10 years after viral eradication in patients with hepatitis C virus.

Published in:

Journal of Viral Hepatitis, 2022, v. 29, n. 10, p. 919, doi. 10.1111/jvh.13728

By:

Takashi Kumada;
Hidenori Toyoda;
Satoshi Yasuda;
Takanori Ito;
Kunihiko Tsuji;
Shinichi Fujioka;
Atsushi Hiraoka;
Kazuya Kariyama;
Kazuhiro Nouso;
Toru Ishikawa;
Tsutomu Tamai;
Toshifumi Tada;
Junko Tanaka

Publication type:

Article

Utility of FIB4-T as a Prognostic Factor for Hepatocellular Carcinoma.

Published in:

Cancers, 2019, v. 11, n. 2, p. 203, doi. 10.3390/cancers11020203

By:

Kariyama, Kazuya;
Nouso, Kazuhiro;
Toyoda, Hidenori;
Tada, Toshifumi;
Hiraoka, Atsushi;
Tsuji, Kunihiko;
Itobayashi, Ei;
Ishikawa, Toru;
Wakuta, Akiko;
Oonishi, Ayano;
Kumada, Takashi;
Kudo, Masatoshi

Publication type:

Article